Table 1.
Baseline characteristics and values of clinical outcome measures before and after treatment.
| All Patients (n = 28) | Group 1: 2 Fractures (n = 6) | Group 2: >2 Fractures (n = 22) | p-Value between-Group in T0 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | p-Value | T0 | T1 | p-Value | T0 | T1 | p-Value | ||
| Age (years) | 66.5 ± 5.3 | 65.5 ± 7.6 | 66.8 ± 4.6 | 0.71 | ||||||
| BMI (kg/m2) | 26.5 ± 4.0 | 24.0 ± 4.6 | 27.2 ± 3.6 | 0.16 | ||||||
| NRS | 6.5 (1.0) | 5.0 (2.0) | <0.05 | 5.0 (2.7) | 3.0 (0.7) | 0.54 | 7.0 (1.7) | 6.0 (1.7) | <0.05 | 0.65 |
| SF-36 | 42.2 ± 15.8 | 50.4 ± 13.2 | <0.05 | 45.0 ± 18.5 | 58.0 ± 10.4 | 0.17 | 41.5 ± 15.4 | 48.3 ± 1.2 | 0.12 | 0.48 |
| Mini-OQOL | 47.0 ± 10.0 | 51.9 ± 9.4 | 0.06 | 52.7 ± 8.3 | 55.5 ± 9.5 | 0.59 | 45.5 ± 10.0 | 51.0 ± 9.3 | 0.07 | 0.11 |
| DHI-I | 38.3 ± 25.5 | 32.7 ± 22.1 | 0.38 | 31.5 ± 25.5 | 29.2 ± 25.2 | 0.88 | 40.2 ± 25.8 | 33.7 ± 21.8 | 0.37 | 0.68 |
| TUG | 13.0 (2.0) | 11.5 (2.5) | 0.78 | 12.0 (0.0) | 10.5 (1.0) | <0.05 | 14.0 (1.7) | 12.7 (2.5) | 0.76 | 0.02 |
Abbreviations. BMI: Body Mass Index; NRS: numeric rating scale; SF-36: 36-Item Short Form Survey; Mini-OQOL: Mini-Osteoporosis Quality of Life Questionnaire; DHI-I: Dizziness Handicap Inventory—Italian version; TUG: timed up and go.